Navigation Links
Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
Date:10/26/2008

rse events observed were consistent with expectations for the treatment-experienced HIV-infected population. Importantly, the incidence of malignancy seen across the vicriviroc clinical program has not increased over time even as the cumulative exposure to vicriviroc has increased by numbers of patients and duration of treatment.

"These long-term results demonstrate that vicriviroc added to an optimized background therapy may provide durable viral suppression and sustained elevated CD4 counts in treatment-experienced HIV-infected patients," said Jihad Slim, M.D., division of infectious diseases, Saint Michael's Medical Center, Newark, N.J., and an investigator for the vicriviroc clinical program. "Importantly, vicriviroc was well tolerated, with some patients continuing on treatment for up to four years, and it was not associated with increased liver, CNS or cardiovascular adverse events or with an increased incidence of malignancy in this patient population."

About the Data Analysis

Patients enrolled in the Phase II vicriviroc VICTOR-E1 study(3) (including patients in the placebo arm) and the ACTG 5211 study(4) were eligible to continue on open-label vicriviroc with optimized background therapy at the completion of 48 weeks of treatment in an extension for each study. The vicriviroc dose for all patients was escalated to 30 mg once daily during the open-label treatment period. As there were no dose-related differences in the safety profile, data for all patients receiving vicriviroc were pooled for analysis regardless of the original starting vicriviroc dose. The mean duration of vicriviroc treatment for all patients (N=205) was 96 weeks (range 1-216 weeks).

Analyses were performed on data from all patients who completed at least 12 weeks of vicriviroc treatment (N=196). Virologic response to regimens containing vicriviroc was evidenced within 12 weeks by a significant decrease in virus (HIV RNA) detectable in the blood and was sustained
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Trubion Announces Preliminary Analysis of Phase IIb Results With TRU-015 in Rheumatoid Arthritis
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. Immtech Announces Interim Analysis in Phase III African Sleeping Sickness Trial
5. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
6. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
7. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
8. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
9. Results Of VYVANSE(TM) (lisdexamfetamine dimesylate) Effect Size Analysis Presented at Major Scientific Meeting
10. Progen Presents Additional Analysis of Data from PI-88 Phase 2 Liver Cancer Study at American Association for the Study of Liver Diseases
11. Retrospective Analysis Finds That Initiation of Insulin Glargine in Patients With Type 2 Diabetes was Associated With a Lower Incidence Rate of Myocardial Infarction as Compared With NPH Insulin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... , Aug. 21, 2014  Aptuit LLC ... West Lafayette, Indiana , has enhanced its ... characterization of small and large molecules, including biologic ... the Bruker maXisPlus Q-TOF mass spectrometer. ... , CEO, Aptuit, said, "The expanded large molecule ...
(Date:8/21/2014)... --  Memorial Hermann Health System and The University ... new partnership to provide a new level of specialized breast ... the greater Houston area. ... provider of professional breast radiology services for five of Memorial ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... Texas , Aug. 21, 2014  Vermillion, Inc. ... focused on gynecologic cancers and women,s health, has appointed ... Sales and Managed Markets. Ms. Bauzon has ... and expanding payer coverage for laboratory services companies. She ... recently with PerkinElmer, Inc., where she held the position ...
Breaking Medicine Technology:Aptuit SSCI Adds Ultra High Resolution Q-TOF Mass Spectrometer for Large & Small Molecule Analyses 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Vermillion Appoints Holly B. Bauzon as VP of Sales and Managed Markets 2
... Industry-Funded Immune Globulin Study Uncovers Sample,Manipulation, Design ... -- An analysis,released today critically examined a ... autism and Rh immune globulin,(RhIg) injections, some ... extensive design flaws, the,analysis uncovered manipulation of ...
... OSS, the Netherlands, June 27, 2007-Organon, the human,healthcare ... two,out of three Phase III clinical trials with ... have reached,their randomization target. , ,Corifollitropin alfa ... first of a new class of gonadotropins (a ...
Cached Medicine Technology:Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 2Two Phase III clinical trials on corifollitropin alfa (Org 36286),reach randomization target 3
(Date:8/21/2014)... August 21, 2014 Pulmonary Hypertension ... an Education Forum for PH patients and families ... Pulmonary Hypertension Association – the country’s ... ways to prevent and cure pulmonary hypertension (PH) ... the functioning of the heart and can lead ...
(Date:8/21/2014)... 2014 Improv performers from Fun House ... dementia at Silverado Turtle Creek memory care community in ... entertainers ranging from ages 10 to 16, delivers a ... 40-minute set. The troupe's philosophy is that improv is ... them to touch audiences regardless of their circumstance — ...
(Date:8/21/2014)... University of Texas MD Anderson Cancer Center today announced ... specialized breast screening at a network of community breast ... in late November, MD Anderson will become the exclusive ... Memorial Hermann,s 10 breast care centers, located in Memorial ... Over time, the network will expand to Memorial Hermann,s ...
(Date:8/21/2014)... -- Researchers have pinpointed the environmental source of fungal ... California for decades. It literally grows on trees. , ... a 13-year-old girl, who spent the summer gathering soil ... hit by infections of the fungus named Cryptococcus ... , which encompasses a number of species including ...
(Date:8/21/2014)... women born at a low or very low birth ... type 2 diabetes. The findings, which appear in ... occurrence of type 2 diabetes in African American populations, ... , Researchers from Boston University,s Slone Epidemiology Center followed ... Health Study over the course of 16 years, analyzing ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2Health News:MD Anderson and Memorial Hermann to operate breast screening network across Houston area 2Health News:Fungus deadly to AIDS patients found to grow on trees 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2
... has found a strong relationship between negative mood and ... at London Health Sciences Centre , London, Canada, said ... the importance of couples emotional health during IVF treatment, ... ,A reduction in the incidence of multiple pregnancies ...
... be given some tips on how to raise their kids ... government is hoping that its 23million pounds scheme of using ... fathers, as it makes the use of male-friendly gadgets and ... ,Under the new initiative, "Parent Know-How", parents will ...
... Moss and superstar footballer David Beckham are among celebrities whose ... auction . ,Artist Rich Clarke, who created the ... 'Dexter' that follows a serial killer, working for the police ... specifically assigned the task of making these artworks by FX ...
... invasive method of treating cancer and they hope ... cancer soon . ,The development of ... result of the efforts of Virginia Techbiomedical engineer ... professor Boris Rubinsky. ,For decades, ...
... has brought some 700 players from 51 countries to Paris ... the growth of the "electronic sports" industry . ... pool of 180,000 dollars (132,000 euros) in prize money at ... the Games-Services company. It was taking place at a convention ...
... the main suspects in fatal neurodegenerative diseases such as ... -- remain mostly a mystery to scientists. Very few ... propagate is not fully understood. ,New insights ... Susan Liebman, distinguished university professor of biological sciences at ...
Cached Medicine News:Health News:Womens Mood Plays a Key Role in Infertility Treatment 2Health News:Scientists Destroy Cancer Cells Using Electric Pulses 2Health News:New Insights into Prion Propogation 2
... and available as a 4-up or ... the wings of the EnduriCuff Plus, ... This is recommended for uses that ... print a lot of wristbands on ...
... a label-based patient ID system which combines the ... and up to six alert or warning ID ... ID band worn by hospital patients. It integrates ... blood banks into a multipurpose ID band that ...
... facilitates bedside labeling of all laboratory ... and nursing personnel where the ID ... combination admitting ID band and designed ... identification system in facilities where alert ...
... The AeroScout Location Receiver is ... AeroScout Visibility System to outdoor and ... robust and sophisticated location measurement capabilities ... devices designed for harsh conditions. The ...
Medicine Products: